GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medicenna Therapeutics Corp (TSX:MDNA) » Definitions » Market Cap

Medicenna Therapeutics (TSX:MDNA) Market Cap : C$169.75 Mil (As of May. 30, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Medicenna Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medicenna Therapeutics's share price for the quarter that ended in Dec. 2023 was C$0.42. Medicenna Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 69.64 Mil. Therefore, Medicenna Therapeutics's market cap for the quarter that ended in Dec. 2023 was C$29.25 Mil.

Medicenna Therapeutics's quarterly market cap declined from Jun. 2023 (C$44.57 Mil) to Sep. 2023 (C$27.86 Mil) but then increased from Sep. 2023 (C$27.86 Mil) to Dec. 2023 (C$29.25 Mil).

Medicenna Therapeutics's annual market cap declined from Mar. 2021 (C$273.63 Mil) to Mar. 2022 (C$91.82 Mil) and declined from Mar. 2022 (C$91.82 Mil) to Mar. 2023 (C$61.28 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medicenna Therapeutics's Enterprise Value for Today is C$147.99 Mil.


Medicenna Therapeutics Market Cap Historical Data

The historical data trend for Medicenna Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicenna Therapeutics Market Cap Chart

Medicenna Therapeutics Annual Data
Trend Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only 21.72 168.48 273.63 91.82 61.28

Medicenna Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.57 61.28 44.57 27.86 29.25

Competitive Comparison of Medicenna Therapeutics's Market Cap

For the Biotechnology subindustry, Medicenna Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicenna Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medicenna Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Medicenna Therapeutics's Market Cap falls into.



Medicenna Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Medicenna Therapeutics's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=C$0.88*69.6375
=C$61.28

Medicenna Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=C$0.42*69.6375
=C$29.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicenna Therapeutics  (TSX:MDNA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Medicenna Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Medicenna Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicenna Therapeutics (TSX:MDNA) Business Description

Traded in Other Exchanges
Address
2 Bloor Street W., 7th Floor, Toronto, ON, CAN, M4W 3E2
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
Executives
Albert George Beraldo Director
Chandra Panchal Director

Medicenna Therapeutics (TSX:MDNA) Headlines

No Headlines